↓ Skip to main content

Dove Medical Press

Phase 1 clinical study of the acute and subacute safety and proof-of-concept efficacy of carbohydrate-derived fulvic acid

Overview of attention for article published in Clinical Pharmacology : Advances and Applications, February 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#29 of 179)
  • High Attention Score compared to outputs of the same age (89th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news
1 news outlet
twitter
2 X users

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
29 Mendeley
Title
Phase 1 clinical study of the acute and subacute safety and proof-of-concept efficacy of carbohydrate-derived fulvic acid
Published in
Clinical Pharmacology : Advances and Applications, February 2012
DOI 10.2147/cpaa.s25784
Pubmed ID
Authors

Justin John Gandy, Johanna Petronella Meeding, Jacques René Snyman, Constance Elizabeth Jansen van Rensburg

Abstract

The purpose of this research was to determine the acute and subacute safety and proof-of-concept efficacy of carbohydrate-derived fulvic acid (CHD-FA).

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 29 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 29 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 6 21%
Researcher 5 17%
Student > Postgraduate 3 10%
Other 2 7%
Student > Bachelor 1 3%
Other 4 14%
Unknown 8 28%
Readers by discipline Count As %
Agricultural and Biological Sciences 7 24%
Pharmacology, Toxicology and Pharmaceutical Science 4 14%
Biochemistry, Genetics and Molecular Biology 3 10%
Medicine and Dentistry 2 7%
Nursing and Health Professions 1 3%
Other 3 10%
Unknown 9 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 November 2021.
All research outputs
#3,415,054
of 25,373,627 outputs
Outputs from Clinical Pharmacology : Advances and Applications
#29
of 179 outputs
Outputs of similar age
#26,462
of 253,530 outputs
Outputs of similar age from Clinical Pharmacology : Advances and Applications
#1
of 5 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 179 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 253,530 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them